Role of Syk and Rac2 in regulation of HIF1alpha and neovascularization.
Role of Syk and Rac2 in regulation of HIF1alpha and neovascularization.
批准号:
7361487
负责人:
DONALD DURDEN
金额:
$4.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2009-09-30
关键词:
AbbreviationsAddressAnimalsAutomobile DrivingBinding SitesBiological ModelsBone MarrowBone Marrow TransplantationCell physiologyCellsComplexDataDevelopmentDiabetic RetinopathyDiseaseEndothelial CellsEnvironmentEventFibronectinsFluorescenceGene TargetingGoalsGuanosine Triphosphate PhosphohydrolasesHematopoieticHypoxiaIn VitroInjuryIntegrinsLaboratoriesMediatingMolecularMolecular TargetMusMyelogenousNeoplasm MetastasisPathogenesisPathway interactionsPatternPlayProcessProtein Synthesis InhibitorsProtein Tyrosine KinaseProteinsReceptor Protein-Tyrosine KinasesRegulationResearchRheumatoid ArthritisRoleSignal TransductionSmall Interfering RNASystemTestingTherapeuticTimeTissuesTo specifyTransfectionTransgenic MiceTyrosine Phosphorylation SiteVascular Endothelial Growth FactorsVitronectinWound Healingangiogenesisbasecell motilityenhanced green fluorescent proteingenetic analysishuman SYK proteinhypoxia inducible factor 1in vivo Modelinnovationinsightmigrationmouse modelmutantneovascularizationnovelpostnatalpromoterras-Related G-Proteinsresearch studytumortumor growthtumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The process of postnatal neovascularization plays a crucial role in pathogenesis of numerous diseases e.g. diabetic retinopathy, tissue remodeling upon injury, rheumatoid arthritis and tumor growth/metastasis. It has been known that endothelial cells (ECs) and its micro environment is the key for regulation of neovascularization/angiogenesis. However, the signal transduction events underlying this complex process are not well understood. The objective of this proposal is to gain insight the regulatory network in ECs for HIF11 accumulation and neovascularization. Our preliminary genetic analysis of Syk-/+ or Syk-/+; Rac2-/+ mice reveal a requirement of Syk for integrin induced activation of Rac2 and hypoxia induced stabilization of HIF11. We hypothesize that Syk-Vav1-Rac2 signaling axis exists in ECs and plays an obligate role in neovascularization via HIF11 stabilization. Preliminary data from our laboratory also suggest that specific region of Syk (Y342 and Y346 at B linker region, those are cognate binding sites for Vav and PLC3 respectively) appear to be involved in the activation of Rac2 but not Rac1 downstream of integrin signaling and migration. We propose in our Aim1 to determine Syk-Rac2 signaling axis a possible focal point for HIF11 stabilization. In Aim 2 we propose to evaluate the role of Syk-Rac2 signaling axis in postnatal neovascularization. Considering the importance of postnatal neovascularization, the identification of a novel molecular pathway, Syk-Vav1-Rac2 signaling axis, will result in the development of innovative therapeutic strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dual PI3K/BRD4 Inhibitory Chemotype for Maximum Inhibition of MYC and Cancer
-
批准号:9828553
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:DONALD DURDEN
-
依托单位:
Role of PTEN and PI-3 kinase in medulloblastomagenesis
-
批准号:9312006
-
项目类别:
-
资助金额:$31.56万
-
财政年份:2017
-
负责人:DONALD DURDEN
-
依托单位:
Role of PTEN and PI-3 Kinase in Medulloblastomagenesis
-
批准号:10681197
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2017
-
负责人:DONALD DURDEN
-
依托单位:
Dual PI3K/BRD4 Inhibitory Chemotype for Maximum Inhibition of MYC and Cancer
-
批准号:10833761
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2017
-
负责人:DONALD DURDEN
-
依托单位:
Role of PTEN and PI-3 Kinase in Medulloblastomagenesis
-
批准号:10231271
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2017
-
负责人:DONALD DURDEN
-
依托单位:
Role of PTEN and PI-3 Kinase in Medulloblastomagenesis
-
批准号:10196616
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2017
-
负责人:DONALD DURDEN
-
依托单位:
Dual PI3K/BRD4 Inhibitory Chemotype for Maximum Inhibition of MYC and Cancer
-
批准号:10165036
-
项目类别:
-
资助金额:$48.71万
-
财政年份:2017
-
负责人:DONALD DURDEN
-
依托单位:
Maximizing cancer synthetic lethality using dual PI-3K/PARP inhibitors
-
批准号:9255563
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2016
-
负责人:DONALD DURDEN
-
依托单位:
A Phase I study of a dual PI3K/BRD4 inhibitor, SF1126 in the treatment of hepatocellular carcinoma | IDE: 74,551
-
批准号:9167160
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2016
-
负责人:DONALD DURDEN
-
依托单位:
Maximal MYC control using dual PI-3K/BRD4 (kinase/epigenetic) inhibitors
-
批准号:8834750
-
项目类别:
-
资助金额:$20.9万
-
财政年份:2015
-
负责人:DONALD DURDEN
-
依托单位:
Phase 2 Study of Poly-ICLC in the Treatment of Pediatric Low Grade Gliomas
-
批准号:8764195
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:DONALD DURDEN
-
依托单位:
Phase 2 Study of Poly-ICLC in the Treatment of Pediatric Low Grade Gliomas
-
批准号:8921959
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:DONALD DURDEN
-
依托单位:
Phase 2 Study of Poly-ICLC in the Treatment of Pediatric Low Grade Gliomas
-
批准号:9125663
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:DONALD DURDEN
-
依托单位:
Phase 2 Study of Poly-ICLC in the Treatment of Pediatric Low Grade Gliomas
-
批准号:9326010
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:DONALD DURDEN
-
依托单位:
Role of Syk and Rac2 in regulation of HIF1alpha and neovascularization.
-
批准号:8036465
-
项目类别:
-
资助金额:$14.44万
-
财政年份:2009
-
负责人:DONALD DURDEN
-
依托单位:
Role of Syk and Rac2 in regulation of HIF1alpha and neovascularization.
-
批准号:7844911
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2009
-
负责人:DONALD DURDEN
-
依托单位:
PTEN/AKTp53 signaling axis in tumor induced angiogenesis
-
批准号:6545115
-
项目类别:
-
资助金额:$26.52万
-
财政年份:2002
-
负责人:DONALD DURDEN
-
依托单位:
Rac2 in integrin macrophage function
-
批准号:6595701
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2002
-
负责人:DONALD DURDEN
-
依托单位:
Vascular targeted pan PI-3 kinase inhibitor prodrug, SF1126 for glioma therapy
-
批准号:7892536
-
项目类别:
-
资助金额:$27.66万
-
财政年份:2002
-
负责人:DONALD DURDEN
-
依托单位:
Vascular targeted pan PI-3 kinase inhibitor prodrug, SF1126 for glioma therapy
-
批准号:8067127
-
项目类别:
-
资助金额:$26.83万
-
财政年份:2002
-
负责人:DONALD DURDEN
-
依托单位:
海外基金